Asthma inhaler access dropped from nearly 41% to nearly 35% between 2021 and 2023 among patients 18 and younger prescribed Flovent (fluticasone), researchers found. By comparison, young asthma ...

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

From breaking news to special features, we're on it! Join the NonStop Local Chord group and always be in the know. GSK withdrew the inhaler after a policy change exposed the company to higher ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

GSK withdrew the inhaler after a policy change exposed the company to higher Medicaid rebate costs WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to ...

Young man using medicine dry powder inhaler for treatment asthma or COPD diseases. Pharmaceutical product is used to treat lung inflammation and prevent asthma attack. Close up. A Medicaid policy ...

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...

Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).

The inhaler contains two foil strips with 30 blisters ... One strip contains 50 micrograms (mcg), 100 mcg, or 200 mcg of fluticasone furoate per blister. The other strip contains 25 mcg of ...